UPDATE 1-Auspex Pharma drug curbs movement disorder in Huntington's patients
December 16, 2014 at 17:33 PM EST
Dec 16 (Reuters) - Drug developer Auspex Pharmaceuticals Inc said its drug for treating chorea, or involuntary movement associated with Huntington's disease, met the main goal in a late-stage study.